All-Cause Mortality by Subgroup in Patients with Chronic Obstructive Pulmonary Disease: Post Hoc Analysis of the IMPACT Trial
TP40. TP040 COPD CLINICAL TRIALS AND THERAPIES | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A2241-A2241
10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2241